Gyre Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.

About GYRE

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).

CEO

Han Ying

CEOHan Ying

Employees

Employees5

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1997

Founded1997

Employees

Employees5

GYRE Key Statistics

Market cap

850.85M

Market cap850.85M

Price-Earnings ratio

197.08

Price-Earnings ratio197.08

Dividend yield

—

Dividend yield—

Average volume

523.12K

Average volume523.12K

High today

$10.45

High today$10.45

Low today

$9.26

Low today$9.26

Open price

$10.35

Open price$10.35

Volume

469.73K

Volume469.73K

52 Week high

$19.00

52 Week high$19.00

52 Week low

$6.11

52 Week low$6.11

People also own

Based on the portfolios of people who own GYRE. This list is generated using Robinhood data, and it’s not a recommendation.